9VF2
Spirooxindole inhibitor CG-1059 complexed with SARS-Cov-2 3CL protease
This is a non-PDB format compatible entry.
Summary for 9VF2
| Entry DOI | 10.2210/pdb9vf2/pdb |
| Descriptor | 3C-like proteinase nsp5, (2~{S})-~{N}-[(2~{S})-1-[(2'~{S},3~{R})-2'-(iminomethyl)-2-oxidanylidene-spiro[1~{H}-indole-3,4'-pyrrolidine]-1'-yl]-4-methyl-1-oxidanylidene-pentan-2-yl]-~{N}-methyl-2-[2,2,2-tris(fluoranyl)ethanoylamino]propanamide (3 entities in total) |
| Functional Keywords | protease, hydrolase |
| Biological source | Severe acute respiratory syndrome coronavirus 2 |
| Total number of polymer chains | 1 |
| Total formula weight | 35245.08 |
| Authors | |
| Primary citation | Tang, X.,Chen, X.,Hou, K.,Fan, W. Spirooxindole inhibitor CG-1059 complexed with SARS-Cov-2 3CL protease To Be Published, |
| Experimental method | X-RAY DIFFRACTION (1.97 Å) |
Structure validation
Download full validation report






